Clinical study of paclitaxel plus nedaplatin versus paclitaxel plus cisplatin in treatment of patients with advanced esophageal carcinoma

Chinese Journal of Cancer Prevention and Treatment

Volumn 17, Issue 9, 2010, Pages 693-695

  Yu, Jie ^a   Wang, Bu Hai ^a   Zhang, Xi Zhi ^a  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

Antineoplastic combined chemotherapy protocols; Esophageal neoplasms drug therapy; Prognosis

Indexed keywords

CISPLATIN; NEDAPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFICACY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VOMITING;

EID: 77956200533     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment[J]. Crit Rev Oncol Hematol, 2002, 42(3):317-325.
2. Taguchi T, Wakui A, Nabeya K, et al. A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S gastrointestinal cancer study group[J]. Gan To Kagaku Ryoho, 1992, 19(4):483-488.
3. Inaba H, Tsuda T, Miyazaki A, et al. Clinical study of the combination of small amount of nedaplatin (CDGP)/5-Fu with radiation for the treatment of esophageal cancer[J]. Nippon Shokakibyo Gakkai Zasshi, 2002, 99(10):1191-1196.
4. Yoshioka T, Gamoh M, Shineha R, et al. A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers[J]. Intern Med, 1999, 38(11):844-848.
5. Kato H, Fukuchi M, Manda R, et al. Efficacy and toxicity of nedaplatin and 52FU with radiation treatment for advanced esophageal carcinomas[J]. Anticancer Res, 2003, 23(4):3493-3498.